Asana Inc. buy BiotechBee
Start price
01.10.23
/
50%
€17.55
Target price
31.10.25
€20.00
Performance (%)
20.60%
End price
02.12.23
€21.17
Summary
This prediction ended on 02.12.23 with a price of €21.17. The prediction had a final performance of 20.60%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Asana Inc. | -7.107% | -7.107% | -53.316% |
| iShares Core DAX® | -1.933% | 2.239% | 16.921% |
| iShares Nasdaq 100 | -0.972% | 0.226% | 5.003% |
| iShares Nikkei 225® | -2.056% | 5.685% | 19.218% |
| iShares S&P 500 | -1.185% | 0.867% | 2.378% |
According to BiotechBee what are the pros and cons of Asana Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Asana Inc. diskutieren
Buy mit Kursziel 20,0
In the thread Trading Asana Inc.
Buy beendet

